Sign In

Matthew Foy

Partner at SROne

Matthew Foy is an accomplished professional with a diverse background in biological sciences, drug discovery, and entrepreneurship. He holds a BSc and MSc in Biological Sciences with a specialization in Cell and Molecular Biology from the University of Oxford. Additionally, he has pursued further studies in Drug Discovery at UCL and completed Entrepreneurship & Strategy Executive Modules at London Business School. Matthew Foy is currently a Partner at SROne, with a rich history of leadership roles and engagements in various organizations across different sectors.

With an impressive track record, Matthew Foy has served as a Board Member at prominent companies such as Fore Biotherapeutics, Decibel Therapeutics, PULMOCIDE LIMITED, Atox Bio, and many others. His extensive experience also includes roles as an Investor at Asceneuron SA, a Consultant / Seed Investor at PRESS London, and involvement in fundraising initiatives for institutions like The Grange Festival and The Royal Ballet School. Matthew Foy's broad expertise spans sectors ranging from biotechnology to film finance, demonstrating his versatility and business acumen.

Highlights

Jun 22 · youtube.com
Starting up - Matthew Foy - YouTube
Starting up - Matthew Foy - YouTube

Related Questions

What are Matthew Foy's main responsibilities at Econic Biosciences?
How did Matthew Foy transition from SR One to Econic Biosciences?
What specific projects is Matthew Foy involved in at Econic Biosciences?
What is Matthew Foy's background in molecular biology and its relevance to his role at Econic Biosciences?
How does Matthew Foy's experience in M&A investment banking influence his work at Econic Biosciences?
Matthew Foy
Matthew Foy, photo 1
Matthew Foy, photo 2
Add to my network

Location

London, England, United Kingdom